Table 2 Blood count of validation cohorts for targeted proteomics

N

29

31

Male, %

100

100

1.0

Smoking, %

100

100

1.0

Pack_years ≥ 30, %

100

100

1.0

Severe COPD, %

100

0

–

White blood cells, WBC

7.55 (1.91)

6.76 (1.8)

0.11

Neutrophil ratio

62.15 (8.25)

59.67 (8.3)

0.25

Lymphocyte ratio

24.95 (7.54)

28.98 (7.52)

0.04

Monocyte ratio

8.77 (2.27)

7.77 (2.09)

0.09

Eosinophil ratio

3.47 (2.89)

2.88 (1.66)

0.34

Basophilic cell ratio

0.66 (0.24)

0.71 (0.23)

0.44

nucleated red cells ratio

0.21 (0.72)

0.10 (0.07)

0.42

Neutrophil count

4.59 (1.47)

4.05 (1.32)

0.15

Lymphocyte count

1.85 (0.8)

1.94 (0.78)

0.66

Monocyte count^b

0.65 (0.28)

0.52 (0.15)

0.027

Eosinophil count

0.26 (0.27)

0.19 (0.13)

0.24

Basophil count

0.22 (0.94)

0.04 (0.05)

0.28

NRBC

5.59 (30.08)

0.01 (0.01)

0.31

Red blood cells, RBC

4.84 (1.0)

4.80 (0.51)

0.85

Hemoglobin, HGB

141.53 (16.42)

145.3 (11.13)

0.31

Hematocrit, HCT

3.29 (11.02)

3.19 (10.43)

0.97

Mean corpuscular volume, MCV

97.17 (47.81)

94.64 (8.52)

0.77

Mean hemoglobin content, MCH

29.45 (4.33)

30.54 (3.16)

0.27

Mean hemoglobin concentration, MCHC

326.9 (10.73)

322.4 (11.9)

0.13

RDW-SD

43.94 (4.89)

43.99 (3.39)

0.96

RDW-CV

14.14 (1.08)

13.56 (1.06)

0.04

Platelet, PLT

255.9 (57.97)

236.1 (60.46)

0.20

Mean platelet volume, MPV

8.14 (1.04)

8.76 (0.94)

0.019

PDW

16.50 (1.2)

16.19 (1.65)

0.41

PCT

0.21 (0.04)

0.20 (0.05)

0.97